Concepedia

Chrysostomos Kalyvas

CK

7

Publications

120

Citations

7

H-Index

2018

Active since

Affiliations

MSD (Belgium)(Current)

Medizinische Hochschule Hannover

Montefiore Medical Center

Albert Einstein College of Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

Chrysostomos Kalyvas is an author at MSD (Belgium) specializing in engineering, time-varying confounding, and epidemiology.

ORCID

Top concepts

Publications per year

2018–2024

7

Publications

7

Quantifying the robustness of primary analysis results: A case study on missing outcome data in pairwise and network meta‐analysis

Loukia M. Spineli, Chrysostomos Kalyvas, Katerina Papadimitropoulou · Research Synthesis Methods · 2021 · 25 citations · Full text

, , +16

Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison

Balázs Halmos, Thomas Burke, Chrysostomos Kalyvas et al. · Lung Cancer · 2021 · 22 citations · Full text

A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC

Balázs Halmos, Thomas Burke, Chrysostomos Kalyvas et al. · Cancers · 2020 · 21 citations · Full text

Low awareness of the transitivity assumption in complex networks of interventions: a systematic survey from 721 network meta-analyses

Loukia M. Spineli, Chrysostomos Kalyvas, Juan José Yepes-Núñez et al. · BMC Medicine · 2024 · 18 citations · Full text

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

Walter P. Maksymowych, Vibeke Strand, Peter Nash et al. · European Journal of Rheumatology · 2018 · 14 citations · Full text

Rows per page

1–5 of 7